CARATOZZOLO, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 789
EU - Europa 360
AS - Asia 270
OC - Oceania 1
SA - Sud America 1
Totale 1.421
Nazione #
US - Stati Uniti d'America 786
IT - Italia 120
CN - Cina 113
SG - Singapore 80
DE - Germania 73
UA - Ucraina 48
HK - Hong Kong 30
TR - Turchia 28
GB - Regno Unito 27
FI - Finlandia 24
IE - Irlanda 17
PL - Polonia 14
FR - Francia 11
RU - Federazione Russa 11
IN - India 8
CZ - Repubblica Ceca 5
IR - Iran 5
BE - Belgio 4
CA - Canada 3
NL - Olanda 3
TW - Taiwan 2
VN - Vietnam 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
ES - Italia 1
ID - Indonesia 1
KR - Corea 1
SE - Svezia 1
Totale 1.421
Città #
Fairfield 128
Ashburn 77
Singapore 68
Woodbridge 65
Houston 50
Wilmington 50
Seattle 47
Cambridge 45
Jacksonville 42
Ann Arbor 39
Chandler 36
Brescia 35
Hong Kong 30
New York 26
Istanbul 25
Nanjing 24
Princeton 24
Helsinki 23
Beijing 21
Dublin 17
Dearborn 15
Munich 14
Warsaw 14
Milan 13
Shanghai 9
Mumbai 7
Jinan 6
Castelli Calepio 5
Nanchang 5
San Giuliano Terme 5
Ardabil 4
Boardman 4
Brussels 4
Changsha 4
Des Moines 4
Ningbo 4
Norwalk 4
Venezia 4
Brno 3
Guangzhou 3
Hebei 3
Kunming 3
Lancaster 3
Lodi 3
London 3
Los Angeles 3
Rende 3
San Diego 3
Toronto 3
Augusta 2
Bologna 2
Catania 2
Dong Ket 2
Hangzhou 2
Kilburn 2
Nürnberg 2
Olomouc 2
Orange 2
Romola 2
Ronciglione 2
San Francisco 2
San Mateo 2
Sassari 2
Taipei 2
Verona 2
Washington 2
Zhengzhou 2
Acton 1
Bienno 1
Cremona 1
Falkenstein 1
Fuzhou 1
Gunzenhausen 1
Jakarta 1
Jiaxing 1
Kocaeli 1
Lanzhou 1
Leawood 1
New Delhi 1
Philadelphia 1
Presezzo 1
Rovato 1
Sabz 1
Scafati 1
Seoul 1
Shenyang 1
Shenzhen 1
Sydney 1
Tianjin 1
Totale 1.088
Nome #
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 165
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 146
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 146
COVID-19 impact on consecutive neurological patients admitted to the emergency department 146
Potentially Serious Drug-Drug Interactions in Older Patients Hospitalized for Acute Ischemic and Hemorrhagic Stroke 122
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 115
Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship? 102
Dementia after Three Months and One Year from Stroke: New Onset or Previous Cognitive Impairment? 92
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 88
Rilevazione di segnali disgrafici e grafo-patologici in un gruppo di persone affette da demenza 47
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 45
The impact of COVID-19 on health status of home-dwelling elderly patients with dementia in East Lombardy, Italy: results from COVIDEM network 31
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease 25
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 25
Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease 24
“Real-world” eligibility for aducanumab depends on clinical setting and patients' journey 20
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum 19
Sex Differences in the Severity and Progression of Neuropsychiatric Symptoms Across Different Dementia Types 18
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study 13
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 12
Association of APOE genotype with blood-brain barrier permeability in neurodegenerative disorders 9
Photophobia and migraine outcome during treatment with galcanezumab 9
Neurophysiological correlates of altered time awareness in Alzheimer's disease and frontotemporal dementia 8
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor 6
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine 6
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients 6
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine 5
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab 5
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination 4
Totale 1.459
Categoria #
all - tutte 8.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.043


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020207 0 0 0 0 20 34 40 33 21 28 22 9
2020/2021302 8 31 18 13 67 48 5 24 15 33 30 10
2021/2022118 6 21 1 4 1 7 10 10 11 7 12 28
2022/2023146 20 5 8 6 15 33 7 8 22 8 7 7
2023/2024178 15 3 24 9 6 39 4 7 33 4 5 29
2024/2025216 16 5 3 141 51 0 0 0 0 0 0 0
Totale 1.459